Previous Close | 34.00 |
Open | 34.00 |
Bid | 33.00 x 0 |
Ask | 34.00 x 0 |
Day's Range | 32.10 - 34.00 |
52 Week Range | 0.63 - 114.00 |
Volume | |
Avg. Volume | 25,073 |
Market Cap | 17.397M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Cannassure Therapeutics Ltd (TASE: CSURE) ("Cannassure"), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.